Associations of visceral adipose tissue adipokines with metabolic disorders in abdominal obesity

Associations of visceral adipose tissue adipokines with metabolic disorders in abdominal obesity

Aim. To identify associations of visceral adipose tissue adipokines with metabolic disorders in abdominal obesity.Materials and methods. The study included 101 individuals aged 25–65 years (51 men). For all patients, questionnaires were completed, anthropometric measurements and 3 measurements of bl...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. V. Tuzovskaia, Ya. V. Polonskaya, E. V. Garbuzova, E. V. Kashtanova, Yu. I. Ragino
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2025-07-01
Series:	Бюллетень сибирской медицины
Subjects:	adipokine visceral adipose tissue adiponectin adipsin lipocalin-2 pai-1 resistin
Online Access:	https://bulletin.ssmu.ru/jour/article/view/6059
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prevalence of some internal diseases depending on the adipokine level in people under 45 years of age
by: E. V. Kashtanova, et al.
Published: (2024-01-01)

Associations of circulating adipokines and coronary artery disease in young adults
by: A. D. Khudiakova, et al.
Published: (2024-06-01)

Association between ultrasonographically measured visceral fat tissue thickness and proinflammatory adipokines in obesity
by: Crnobrnja Veljko, et al.
Published: (2020-01-01)

Role of epicardial adipose tissue in the pathogenesis of chronic inflammation in heart failure with preserved ejection fraction
by: O. N. Dzhioeva, et al.
Published: (2024-04-01)

Canine obesity, overweight, and adipokine serum concentration are associated with hematological, biochemical, hormonal, and cardiovascular markers
by: Adrian Carzoli, et al.
Published: (2025-02-01)

Adipokines and Adipose Tissue: The Role and Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients with Diabetes or Heart Failure
by: Michalina Mazurkiewicz, et al.
Published: (2025-04-01)

Metabolic and endocrine disorders in obesity in dogs
by: V. V. Horiuk, et al.
Published: (2025-03-01)

Visceral adiposity index in patients with coronary artery disease, obesity and type 2 diabetes
by: A. A. Khorlampenko, et al.
Published: (2020-07-01)

Serum adipsin levels in rheumatic diseases: defining its role in disease activity and progression in rheumatoid arthritis and axial spondyloarthritis
by: Marta Novella-Navarro, et al.
Published: (2025-08-01)

Unmasking metabolic clues: adipsin, irisin and osteopontin as biomarkers in polycystic ovary syndrome and their impact on metabolic dynamics: a case-control study
by: Fatma Nur Duzenli, et al.
Published: (2025-07-01)

From fat to facts: the potential of adipokine and insulin dosing in obese feline patients
by: Laura Cernat, et al.
Published: (2025-08-01)

Adiposity: A Seed of Depression
by: Dhivya Selvaraj, et al.
Published: (2024-04-01)

Expression analysis of microRNA and lncRNA in visceral adipose tissue of obese and non-obese individuals
by: A. Bairqdar, et al.
Published: (2025-06-01)

Adipokines as Potential Biomarkers in Pregnancy: A Naturalistic Study of Adipokines in Pregnant Women and Newborns
by: Cristina Mihaela Ormindean, et al.
Published: (2025-04-01)

Unveiling the perfect workout: exercise modalities and dosages to ameliorate adipokine dysregulation in individuals with overweight and obesity: a systematic review with pairwise, network, and dose–response meta-analyses
by: Hai Wang, et al.
Published: (2025-08-01)

Changes in the levels of adipokines in newly diagnosed pulmonary tuberculosis patients in case of treatment failure
by: R. M. Yasinskyi, et al.
Published: (2020-04-01)

Adipokines and personal anxiety in individuals aged 25-44 years
by: V. V. Gafarov, et al.
Published: (2025-07-01)

Adipokines as biochemical marker of polycystic ovary syndrome in adolescents – review
by: Dominika Orszulak, et al.
Published: (2025-05-01)

Sputum as a source of adipokines in bronchial asthma
by: V. N. Mineev, et al.
Published: (2014-09-01)

Effect of Orlistat Treatment on Visceral Adiposity Index (VAI) in Obese Patients
by: İhsan Solmaz, et al.
Published: (2025-06-01)

Metabolic Syndrome: the Influence of Adipokines on the L-Arginine-NO Synthase-Nitric Oxide Signaling Pathway
by: L. A. Kuznetsova
Published: (2021-06-01)

Evaluating the visceral adiposity inflammatory index for enhanced stroke risk assessment
by: Qun Xiao, et al.
Published: (2025-04-01)

The effect of continuous aerobic exercise and periodized resistance training on plasma levels of adiponectin and resistin in sedentary obese adolescents
by: A Steki Oregani, et al.
Published: (2016-12-01)

Integrating adipsin with novel cardiometabolic and inflammatory indices for enhanced early prediction of gestational diabetes mellitus: a prospective cohort study
by: Meizhi Cai, et al.
Published: (2025-05-01)

Impact of Obesity Visceral Adiposity and Metabolic Syndrome on Male Fertility
by: Esra Bahar Gur, et al.
Published: (2021-12-01)

OPPORTUNITIES FOR THE USE OF VISCERAL OBESITY INDEX IN METABOLIC SYNDROME DIAGNOSTICS AND PROGNOSIS OF ITS COMPLICATION RISK
by: R. A. Libis, et al.
Published: (2014-09-01)

The state of the main arteries, vascular age in patients with arterial hypertension and obesity: the role of leptin and adiponectin
by: M. E. Statsenko, et al.
Published: (2019-02-01)

Higher serum resistin levels and increased frailty risk in older adults: Implications beyond metabolic function
by: Beom-Jun Kim, et al.
Published: (2025-05-01)

Correlations between circulating adipokines and hepatocellular carcinoma: a Systematic Review and meta-analysis
by: Yani Ke, et al.
Published: (2025-06-01)

The content of adiponectin, resistin in serum and their ratio in patients with chronic heart failure in overweight and obesity depending on severity of disease, body mass index, age, gender and myocardium contractile ability
by: P. P. Bidzilya
Published: (2017-06-01)

Serum adipokine concentrations in patients with type 2 diabetes: the relationships with distribution, hypertrophy and vascularization of subcutaneous adipose tissue
by: Vadim V. Klimontov, et al.
Published: (2019-10-01)

TRANSPLANTATION OF ADIPOSE TISSUE AS A REPLACEMENT THERAPY
by: V. G. Ablamunits, et al.
Published: (2014-12-01)

Connecting bone metastasis, adipose tissue and adipokines: How does physical activity fit?
by: Paola Maroni, et al.
Published: (2024-09-01)

Algorithm for radiological examination of visceral obesity in patients with metabolic syndrome
by: N. M. Suslyayeva, et al.
Published: (2012-10-01)

Effects of Extracted Phenolic Compounds from Grape Seeds on Leptin, Adiponectin and Resistin Levels in Rats Fed with High Fat Foods
by: Entedhar Rifaat Sarhat, et al.
Published: (2018-04-01)

The association between serum leptin, adiponectin and resistin levels with chronic kidney disease with and without hemodialysis patients
by: Maha Elttayef Jasim, et al.
Published: (2025-06-01)

Adipokine levels and T786C polymorphism of eNOS gene promoter correlation in patients with arterial hypertension
by: Pidruchna Svitlana, et al.
Published: (2025-01-01)

Visceral Obesity: Terminology, Measurement, and Its Correlation with Inflammation
by: Anna A. Tarabrina, et al.
Published: (2022-10-01)

Association of cumulative exposure to Chinese visceral adiposity index and gastrointestinal cancer: a prospective cohort study
by: Jiaxing Li, et al.
Published: (2025-07-01)

ADIPOKINES CONTENT AND ECHOCARDIOGRAPHY INDICATORS OF WOMEN WITH HYPOTHYROIDISM
by: I. Yu. Kapralova, et al.
Published: (2015-01-01)